VBL surges ahead of presentation

Shares of VBL Therapeutics (Nasdaq: VBLT) surged $1.30 to $6.04 ahead of its presentation today at the BioCentury 22nd Annual Future Leaders in the Biotech Industry Conference.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.